77 related articles for article (PubMed ID: 17072629)
1. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
[TBL] [Abstract][Full Text] [Related]
2. MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
Pellegrini C; Botta F; Massi D; Martorelli C; Facchetti F; Gandini S; Maisonneuve P; Avril MF; Demenais F; Bressac-de Paillerets B; Hoiom V; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Marrett L; Zanetti R; Dwyer T; Thomas NE; Begg CB; Berwick M; Puig S; Potrony M; Nagore E; Ghiorzo P; Menin C; Manganoni AM; Rodolfo M; Brugnara S; Passoni E; Sekulovic LK; Baldini F; Guida G; Stratigos A; Ozdemir F; Ayala F; Fernandez-de-Misa R; Quaglino P; Ribas G; Romanini A; Migliano E; Stanganelli I; Kanetsky PA; Pizzichetta MA; García-Borrón JC; Nan H; Landi MT; Little J; Newton-Bishop J; Sera F; Fargnoli MC; Raimondi S; ; ;
Lancet Child Adolesc Health; 2019 May; 3(5):332-342. PubMed ID: 30872112
[TBL] [Abstract][Full Text] [Related]
3. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
[TBL] [Abstract][Full Text] [Related]
4. Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.
Manganelli M; Guida S; Ferretta A; Pellacani G; Porcelli L; Azzariti A; Guida G
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356109
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin-1 receptor (MC1R): a review for dermatologists.
Guida S; Puig S; DI Resta C; Sallustio F; Mangano E; Stabile G; Longo C; Pellacani G; Guida G; Rongioletti F
Ital J Dermatol Venerol; 2024 Jun; 159(3):285-293. PubMed ID: 38376504
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.
Su DG; Djureinovic D; Schoenfeld D; Marquez-Nostra B; Olino K; Jilaveanu L; Kluger H
JCO Precis Oncol; 2024 Apr; 8():e2300702. PubMed ID: 38662983
[TBL] [Abstract][Full Text] [Related]
7. Loss of MC1R signaling implicates TBX3 in pheomelanogenesis and melanoma predisposition.
Berns HM; Watkins-Chow DE; Lu S; Louphrasitthiphol P; Zhang T; Brown KM; Moura-Alves P; Goding CR; Pavan WJ
bioRxiv; 2023 Mar; ():. PubMed ID: 37090624
[TBL] [Abstract][Full Text] [Related]
8. Assessing the genetic risk of nodular melanoma using a candidate gene approach.
Stark MS; Sturm RA; Pan Y; Smit DJ; Kommajosyula V; Lee KJ; Jagirdar K; McLean C; Duffy DL; Soyer HP; Mar VJ
Br J Dermatol; 2024 Jan; 190(2):199-206. PubMed ID: 37766469
[TBL] [Abstract][Full Text] [Related]
9. Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population.
Tomei S; Adams S; Uccellini L; Bedognetti D; De Giorgi V; Erdenebileg N; Ascierto ML; Reinboth J; Liu Q; Bevilacqua G; Wang E; Mazzanti C; Marincola FM
Med Oncol; 2012 Dec; 29(5):3456-61. PubMed ID: 22618666
[TBL] [Abstract][Full Text] [Related]
10. Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.
Monroe JD; Basheer F; Gibert Y
Cells; 2021 May; 10(5):. PubMed ID: 34067095
[TBL] [Abstract][Full Text] [Related]
11. Effects of the IL6 -174G>C promoter polymorphism and IL-6 serum levels on the progression of cutaneous malignant melanoma.
Vlaykova T; Kurzawski M; Tacheva T; Dimov D; Anastasov A; Vlaykova D; Miteva A; O'donoghue N; Drozdzik M
Oncol Lett; 2020 Aug; 20(2):1781-1791. PubMed ID: 32724421
[TBL] [Abstract][Full Text] [Related]
12. MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.
Stratigos AJ; Fargnoli MC; De Nicolo A; Peris K; Puig S; Soura E; Menin C; Calista D; Ghiorzo P; Mandala M; Massi D; Rodolfo M; Del Regno L; Stefanaki I; Gogas H; Bataille V; Tucker MA; Whiteman D; Nagore E; Landi MT
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2134-2141. PubMed ID: 30098061
[TBL] [Abstract][Full Text] [Related]
13. Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.
Lei Z; Liu T; Li X; Xu X; Fan D
Int J Clin Exp Med; 2015; 8(1):377-86. PubMed ID: 25785008
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.
Davies JR; Chang YM; Bishop DT; Armstrong BK; Bataille V; Bergman W; Berwick M; Bracci PM; Elwood JM; Ernstoff MS; Green A; Gruis NA; Holly EA; Ingvar C; Kanetsky PA; Karagas MR; Lee TK; Le Marchand L; Mackie RM; Olsson H; Østerlind A; Rebbeck TR; Reich K; Sasieni P; Siskind V; Swerdlow AJ; Titus L; Zens MS; Ziegler A; Gallagher RP; Barrett JH; Newton-Bishop J
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):817-24. PubMed ID: 25713022
[TBL] [Abstract][Full Text] [Related]
15. Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.
Peng H; He Q; Zhu J; Peng C
Tumour Biol; 2013 Apr; 34(2):675-81. PubMed ID: 23184764
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies.
Raimondi S; Gandini S; Fargnoli MC; Bagnardi V; Maisonneuve P; Specchia C; Kumar R; Nagore E; Han J; Hansson J; Kanetsky PA; Ghiorzo P; Gruis NA; Dwyer T; Blizzard L; Fernandez-de-Misa R; Branicki W; Debniak T; Morling N; Landi MT; Palmieri G; Ribas G; Stratigos A; Cornelius L; Motokawa T; Anno S; Helsing P; Wong TH; Autier P; García-Borrón JC; Little J; Newton-Bishop J; Sera F; Liu F; Kayser M; Nijsten T; ;
BMC Med Res Methodol; 2012 Aug; 12():116. PubMed ID: 22862891
[TBL] [Abstract][Full Text] [Related]
17. No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.
Schäfer A; Emmert S; Kruppa J; Schubert S; Tzvetkov M; Mössner R; Reich K; Berking C; Volkenandt M; Pföhler C; Schön MP; Vogt T; König IR; Reichrath J
Arch Dermatol Res; 2012 Jul; 304(5):353-61. PubMed ID: 22576141
[TBL] [Abstract][Full Text] [Related]
18. The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.
Loser K; Brzoska T; Oji V; Auriemma M; Voskort M; Kupas V; Klenner L; Mensing C; Hauschild A; Beissert S; Luger TA
PLoS One; 2010 Feb; 5(2):e8958. PubMed ID: 20126537
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.
Chaudru V; Lo MT; Lesueur F; Marian C; Mohamdi H; Laud K; Barrois M; Chompret A; Avril MF; Demenais F; Bressac-de Paillerets B
Fam Cancer; 2009; 8(4):371-7. PubMed ID: 19484507
[TBL] [Abstract][Full Text] [Related]
20. In silico mutagenesis: a case study of the melanocortin 4 receptor.
Bromberg Y; Overton J; Vaisse C; Leibel RL; Rost B
FASEB J; 2009 Sep; 23(9):3059-69. PubMed ID: 19417090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
